newsfilter
← Latest News
PR Newswire·

Edgewise Therapeutics to Participate in Upcoming Investor Conferences

  • Edgewise Therapeutics, Inc. announced its management will participate in the Guggenheim 3rd Annual Healthcare Innovation Conference fireside chat on Tuesday, November 10, 2026, at 8:00 am ET.
  • The company will also attend the 2026 Truist Biopharma Symposium fireside chat on Thursday, November 12, 2026, at 10:30 am ET.
  • Webcasts for both events will be available on the Edgewise Events & Presentations page with limited-time replays.
  • Edgewise Therapeutics is a clinical-stage cardiovascular biopharmaceutical company focused on developing small molecule therapies to fine-tune cardiac muscle function.
  • The company is advancing novel treatments for symptomatic hypertrophic cardiomyopathy & heart failure by addressing cardiac equilibrium.
Company
Edgewise Therapeutics
Keywords
Edgewise Therapeutics